REDWOOD CITY, Calif.–(BUSINESS WIRE)–Juvena Therapeutics, a clinical-stage biotechnology company whose AI-enabled regenerative biologics are designed to restore tissue function, today announced its $33.5 million Series B. The round was led by Bison Ventures with participation…
According to filings with the U.S. Securities and Exchange Commission, Juvena Therapeutics is raising up to $41,000,000.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold…
Redwood City, CA – According to filings with the U.S. Securities and Exchange Commission, Juvena Therapeutics is raising $41,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Hanadie Yousef played…